Emulation of a phase 3 study comparing Rituximab with Dimethyl Fumarate in early Relapsing-Remitting Multiple Sclerosis

Data sources

• Data source(s), other:
  Swedish multiple sclerosis registry (SMSreg)
• Data sources (types):
  Disease registry

Use of a Common Data Model (CDM)

• CDM mapping:
  Yes

CDM Mappings

Data quality specifications

• Check conformance:
  Unknown
• Check completeness:
  Unknown
• Check stability:
  Unknown
• Check logical consistency:
  Unknown

Data characterisation

• Data characterisation conducted:
  No